As of 2025-05-17, the Relative Valuation of Addex Therapeutics Ltd (ADXN.SW) is 0.31 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CHF, the upside of Addex Therapeutics Ltd based on Relative Valuation is 458.3%.
The range of the Relative Valuation is 0.26 - 0.41 CHF.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 10.0x | 9.4x |
| Forward P/E multiples | 9.3x - 14.0x | 11.6x |
| Fair Price | 0.26 - 0.41 | 0.31 |
| Upside | 371.0% - 640.9% | 458.3% |
| Date | P/E |
| 2025-05-14 | 1.98 |
| 2025-05-13 | 1.94 |
| 2025-05-12 | 2.03 |
| 2025-05-09 | 1.98 |
| 2025-05-08 | 1.91 |
| 2025-05-07 | 1.91 |
| 2025-05-06 | 2.02 |
| 2025-05-05 | 2.04 |
| 2025-05-02 | 2.01 |
| 2025-04-30 | 2.04 |
| 2025-04-29 | 1.96 |
| 2025-04-28 | 1.98 |
| 2025-04-25 | 1.96 |
| 2025-04-24 | 1.72 |
| 2025-04-23 | 1.81 |
| 2025-04-22 | 1.71 |
| 2025-04-17 | 1.71 |
| 2025-04-16 | 1.71 |
| 2025-04-15 | 1.71 |
| 2025-04-14 | 1.79 |
| 2025-04-11 | 1.70 |
| 2025-04-10 | 1.84 |
| 2025-04-09 | 1.64 |
| 2025-04-08 | 1.84 |
| 2025-04-07 | 1.84 |
| 2025-04-04 | 1.86 |
| 2025-04-03 | 1.75 |
| 2025-04-02 | 1.74 |
| 2025-04-01 | 1.71 |
| 2025-03-31 | 1.77 |
| 2025-03-28 | 1.85 |
| 2025-03-27 | 1.82 |
| 2025-03-26 | 1.88 |
| 2025-03-25 | 1.88 |
| 2025-03-24 | 1.98 |
| 2025-03-21 | 1.94 |
| 2025-03-20 | 1.97 |
| 2025-03-19 | 1.88 |
| 2025-03-18 | 1.97 |
| 2025-03-17 | 1.89 |
| 2025-03-14 | 1.91 |
| 2025-03-13 | 1.88 |
| 2025-03-12 | 1.88 |
| 2025-03-11 | 1.90 |
| 2025-03-10 | 1.94 |
| 2025-03-07 | 1.94 |
| 2025-03-06 | 1.84 |
| 2025-03-05 | 2.05 |
| 2025-03-04 | 2.05 |
| 2025-03-03 | 2.20 |